Everest Medicines' Partner Pfizer Announces European Commission Approves VELSIPITY® for Patients with Moderately to Severely Active Ulcerative ColitisPRNewsWire • 02/22/24
These 3 Dividend Stocks Yield More Than 5% but Their Payout Ratios Are Over 100%. Are Dividend Cuts Coming?The Motley Fool • 02/21/24
Wall Street Favorites: 7 Long-Term Stocks With Strong Buy Ratings for February 2024InvestorPlace • 02/20/24
2 Ultra-High-Yield Dividend Stocks Billionaires Can't Stop Buying, and 1 They Can't Sell Fast EnoughThe Motley Fool • 02/20/24
European Commission Approves Pfizer's VELSIPITY® for Patients with Moderately to Severely Active Ulcerative ColitisBusiness Wire • 02/19/24